Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway (Q81521829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Aurore Miellot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ren Zhu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Séverine Diem

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marie-Christophe Boissier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

André Herbelin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Natacha Bessis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

3704-3713

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

Rheumatoid arthritis. Pathophysiology and implications for therapy

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Th1/Th2 cytokine balance in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Natural killer T cells: natural or unnatural regulators of autoimmunity?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

CD1: antigen presentation and T cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Lysosomal glycosphingolipid recognition by NKT cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Immunisation against heterologous type II collagen induces arthritis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Collagen-induced arthritis, an animal model of autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Collagen-induced arthritis as a model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Innate immune responses support adaptive immunity: NKT cells induce B cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535235

7 January 2021

Identifiers

DOI

10.1002/EJI.200535235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304639%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference